A Phase I-II Trial of a DNA Vaccine with a PSMA27/pDOM Fusion Gene Given by Intramuscular Injection in HLA2+ [human leucocyte antigen-2-positive] Patients with Prostate Carcinomas with or without Electroporation

Trial Profile

A Phase I-II Trial of a DNA Vaccine with a PSMA27/pDOM Fusion Gene Given by Intramuscular Injection in HLA2+ [human leucocyte antigen-2-positive] Patients with Prostate Carcinomas with or without Electroporation

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 05 Aug 2009

At a glance

  • Drugs Prostate cancer DNA vaccine (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Inovio Pharmaceuticals
  • Most Recent Events

    • 05 Aug 2009 Results published in Human Gene therapy, according to an Inovio media release.
    • 05 Jun 2008 Interim data was presented at the American Society of Gene Therapy 11th Annual meeting.
    • 10 May 2008 Interim results data in 20 patients have been reported in a media release from Inovio.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top